Amgen 2020 outlook falls short of Street estimates, shares down 3%
Share:
(Reuters) - Amgen Inc on Thursday forecast 2020 earnings well short of current Wall Street estimates, sending shares of the largest U.S. biotechnology company down 3%. For the full year, the company forecast earnings of $14.85 to $15.60 per share on revenue as high as $25.6 billion (19.5 billion pounds). Analysts had estimated 2020 adjusted earnings of $16.14 on revenue of $25.5 billion, according to Refinitiv IBES data.A company official attributed the difference to lower interest income and..